Altius Minerals heads into its May 8 Q1 results with short interest building sharply and a sector-wide sell-off compressing the stock — yet the borrow market tells a story that is far less dramatic than the headline numbers suggest.
The most striking positioning move this week is the jump in short interest. Shorts in ALS climbed roughly 25% over the past week to reach about 1.97% of the free float — a meaningful build from the ~1.6% level that prevailed through mid-April. The move is notable in absolute terms, though short interest at under 2% of the float remains modest. What makes it worth watching is the pace: shares short rose from around 730,000 to above 910,000 in fewer than five sessions, the fastest accumulation in the 30-day window. The ORTEX short score, which has drifted up from 33.7 to 36.3 over the past two weeks, reflects that growing lean — though at 36 on a 100-point scale the reading is far from extreme.
The borrow market pushes back against any squeeze narrative, however. Availability is ample — and cost to borrow has actually collapsed over the same period that short interest was rising, dropping more than 75% from its March highs to just 0.63% annualised. That is the cheapest borrow has been all year. In late March, ALS shorts were paying nearly 3.7% to hold positions; today it costs next to nothing. When borrow gets cheaper as shorts pile in, it typically means supply of lendable shares is rising alongside demand, which is exactly what the availability data supports. There is no squeeze pressure here.
The Street's current read is modestly constructive. Raymond James raised its price target to C$52 in the week of April 22, and the consensus mean target of C$51.36 sits roughly 4% above Tuesday's close of C$49.41 — a thin but positive gap. Altius pre-announced Q1 royalty revenue of C$26.4 million on April 21, and analyst EPS estimates for full-year 2026 were trimmed modestly around the same time, likely reflecting commodity price moves across the portfolio. Factor scores add nuance: the dividend score ranks at the 99th percentile, underscoring the royalty model's income profile, while EPS momentum over 30 days ranks at the 79th percentile — one of the stronger readings in the peer group.
The institutional picture shows two noteworthy developments. Waratah Capital Advisors entered the register with a 6.65% stake — its entire reported position established in the March 16 filing — making it the second-largest holder behind Hamblin Watsa at 8.4%. Mirae Asset added roughly 460,000 shares in the most recent period, lifting its stake to 3%. On the insider side, CEO Brian Dalton bought 1,600 shares at C$41.32 on March 19 — a modest open-market addition — while on March 20 a cluster of executives executed a mix of option-related sells and concurrent market purchases, a common compensation exercise pattern that carries limited directional signal. The net 90-day insider number is distorted by the Waratah institutional entry and should be read with caution as a directional indicator.
The wider sector context is relevant. Peers including FNV, WPM, and TFPM all fell 3-9% on the week, with WPM and TXG each down more than 8%. ALS declined 2.1% over the same stretch — a notably smaller drawdown than its royalty and streaming peers, suggesting some relative resilience even as precious metals complex broadly sold off. The May 8 print, with Q1 royalty revenue pre-guided at C$26.4 million, narrows the revenue surprise potential significantly — leaving margin delivery, portfolio asset updates, and any commentary on Altius's clean energy royalty pipeline as the main variables worth tracking heading into results.
See the live data behind this article on ORTEX.
Open ALS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
